Title |
Allogeneic hematopoietic stem cell transplantation in mycosis fungoides
|
---|---|
Published in |
Anais Brasileiros de Dermatologia, December 2013
|
DOI | 10.1590/abd1806-4841.20132365 |
Pubmed ID | |
Authors |
Angelo Atalla, Abrahão Elias Hallack Neto, Denise Bittencourt Siqueira, Gabriela Cumani Toledo |
Abstract |
Mycosis Fungoides is typically an indolent disease in early stages. However, approximately 30% of patients have advanced staged disease at presentation and 20% will develop it at some time. These patients have a poorer prognosis with a median survival of 2-4 years. The only curative option for mycosis fungoides may be hematopoietic allogeneic stem cell transplantation. We report the case of a patient with mycosis fungoides in an advanced stage (IIB), refractory to treatment options. She underwent allogeneic hematopoietic stem-cell transplantation (allo-HSCT). The patient remains in complete remission nineteen months after allo-HSCT. Allogeneic transplantation can alter the natural history of mycosis fungoides and should be considered in patients who have refractory disease or short-lived responses with standard therapies. |
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.